Private Management Group Inc. lifted its position in Avantor, Inc. (NYSE:AVTR – Free Report) by 50.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,456,859 shares of the company’s stock after buying an additional 823,572 shares during the quarter. Private Management Group Inc.’s holdings in Avantor were worth $28,156,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also recently modified their holdings of AVTR. EverSource Wealth Advisors LLC lifted its holdings in shares of Avantor by 119.1% in the second quarter. EverSource Wealth Advisors LLC now owns 2,187 shares of the company’s stock worth $29,000 after buying an additional 1,189 shares in the last quarter. Private Trust Co. NA raised its stake in Avantor by 46.2% in the fourth quarter. Private Trust Co. NA now owns 2,769 shares of the company’s stock valued at $32,000 after purchasing an additional 875 shares in the last quarter. Strategic Wealth Investment Group LLC purchased a new stake in Avantor in the second quarter valued at approximately $32,000. Los Angeles Capital Management LLC bought a new stake in Avantor during the fourth quarter valued at approximately $32,000. Finally, Osaic Holdings Inc. grew its stake in Avantor by 60.9% in the 2nd quarter. Osaic Holdings Inc. now owns 2,810 shares of the company’s stock worth $38,000 after buying an additional 1,064 shares in the last quarter. 95.08% of the stock is owned by hedge funds and other institutional investors.
Insider Buying and Selling at Avantor
In other news, Director Gregory T. Lucier bought 10,000 shares of the firm’s stock in a transaction that occurred on Friday, May 8th. The shares were bought at an average cost of $8.32 per share, with a total value of $83,200.00. Following the completion of the purchase, the director directly owned 60,000 shares in the company, valued at $499,200. This represents a 20.00% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available at this link. Also, Director Simon Dingemans acquired 25,000 shares of the firm’s stock in a transaction on Friday, May 1st. The stock was purchased at an average price of $8.14 per share, for a total transaction of $203,500.00. Following the transaction, the director directly owned 25,000 shares of the company’s stock, valued at approximately $203,500. This trade represents a ? increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. 0.28% of the stock is owned by insiders.
Analysts Set New Price Targets
Get Our Latest Analysis on AVTR
Avantor Trading Up 0.3%
AVTR stock opened at $9.68 on Friday. The company has a market capitalization of $6.61 billion, a PE ratio of -11.94, a price-to-earnings-growth ratio of 5.60 and a beta of 0.97. Avantor, Inc. has a one year low of $7.26 and a one year high of $15.93. The company’s 50 day moving average price is $8.34 and its two-hundred day moving average price is $9.63. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.17 and a current ratio of 1.76.
Avantor (NYSE:AVTR – Get Free Report) last posted its quarterly earnings results on Wednesday, April 29th. The company reported $0.17 EPS for the quarter, topping the consensus estimate of $0.16 by $0.01. The firm had revenue of $1.58 billion for the quarter, compared to the consensus estimate of $1.54 billion. Avantor had a negative net margin of 8.42% and a positive return on equity of 9.95%. The business’s revenue was up .0% compared to the same quarter last year. During the same period last year, the firm posted $0.23 earnings per share. As a group, analysts predict that Avantor, Inc. will post 0.79 earnings per share for the current fiscal year.
Avantor Company Profile
Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.
Avantor’s offerings are organized across two primary segments.
See Also
- Five stocks we like better than Avantor
- Microsoft Just Gave Investors 3 Dates They Can’t Afford to Ignore
- NVIDIA’s Outlook Gains Momentum: Stock Price to Follow
- The World Cup Is Coming—These 3 Stocks Could Cash In
- Spotify’s “North Star” Outlook Was Music to Investors Ears
Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTR – Free Report).
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.
